Physician profile
Philip N Chaipis
NPI 1760449920
$1,804.57
in general payments reported to CMS, 2019-2025
10 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $821 · 2023: $443 · 2024: $175 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,184.41 | 2021-2023 | Puraply, Affinity |
| Smith+Nephew, INC. | $218.50 | 2024-2025 | Grafix Pl, Collagenase Santyl |
| Progenacare Global, LLC | $107.21 | 2023 | |
| Conmed Corporation | $103.55 | 2024 | Airseal, Conmed Trocars |
| Tactile Systems Technology INC | $48.37 | 2021-2022 | |
| Intuitive Surgical, INC. | $44.48 | 2025 | |
| Cashflow Solutions, LLC | $28.41 | 2022-2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Medtronic, INC. | $27.95 | 2025 | Maxtack |
| Convatec INC. | $21.77 | 2025 | |
| Boston Scientific Corporation | $19.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Chaipis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.